1 – 20 of 36
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
(
- Contribution to journal › Article
- 2020
-
Mark
Structural characterization of covalently stabilized human cystatin c oligomers
(
- Contribution to journal › Article
-
Mark
Kinetic diversity of amyloid oligomers
(
- Contribution to journal › Article
-
Mark
Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
(
- Contribution to journal › Article
-
Mark
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(39). p.24251-24257(
- Contribution to journal › Article
-
Mark
Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
(
- Contribution to journal › Article
-
Mark
Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
(
- Contribution to journal › Article
-
Mark
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
(
- Contribution to journal › Article
- 2019
-
Mark
Lipid Dynamics and Phase Transition within α-Synuclein Amyloid Fibrils
(
- Contribution to journal › Article
-
Mark
Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42
2019) In ACS Chemical Neuroscience(
- Contribution to journal › Article
-
Mark
Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-b aggregates
(
- Contribution to journal › Article
-
Mark
Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
(
- Contribution to journal › Article
- 2018
-
Mark
SAR by kinetics for drug discovery in protein misfolding diseases
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(41). p.10245-10250(
- Contribution to journal › Article
-
Mark
Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide
(
- Contribution to journal › Article
-
Mark
Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes
(
- Contribution to journal › Article
- 2017
-
Mark
Modulation of electrostatic interactions to reveal a reaction network unifying the aggregation behaviour of the Aβ42 peptide and its variants
(
- Contribution to journal › Article
-
Mark
Selective targeting of primary and secondary nucleation pathways in Ab42 aggregation using a rational antibody scanning method
(
- Contribution to journal › Article
-
Mark
Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(30). p.8005-8010(
- Contribution to journal › Article
-
Mark
Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(25). p.6444-6449(
- Contribution to journal › Article
-
Mark
Scaling behaviour and rate-determining steps in filamentous self-assembly
(
- Contribution to journal › Article